Kasabach–Merritt syndrome
Kasabach–Merritt syndrome (pronunciation: kah-suh-bak merr-it sin-drome) is a rare hematologic disorder that typically presents in infancy. The syndrome is characterized by a rapidly growing vascular tumor, thrombocytopenia, and coagulopathy.
Etymology
The syndrome is named after the American pediatricians Katharine Krom Merritt and Haig Haigouni Kasabach who first described the condition in 1940.
Symptoms
The primary symptoms of Kasabach–Merritt syndrome include a rapidly enlarging hemangioma, severe thrombocytopenia, and consumptive coagulopathy. Other symptoms may include anemia, edema, and pain.
Diagnosis
Diagnosis of Kasabach–Merritt syndrome is typically made based on clinical presentation and laboratory findings. Imaging studies such as ultrasound, MRI, or CT scan may be used to further evaluate the extent of the vascular tumor.
Treatment
Treatment of Kasabach–Merritt syndrome often involves a multidisciplinary approach and may include medical therapy, surgical intervention, and supportive care. Medical therapies may include corticosteroids, vincristine, and sirolimus. In severe cases, surgical intervention may be necessary.
Prognosis
The prognosis of Kasabach–Merritt syndrome varies and is dependent on the size and location of the vascular tumor, as well as the severity of the coagulopathy and thrombocytopenia.
See also
External links
- Medical encyclopedia article on Kasabach–Merritt syndrome
- Wikipedia's article - Kasabach–Merritt syndrome
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski